Suppr超能文献

一类增强含GluN2B的N-甲基-D-天冬氨酸受体的四氢异喹啉类N-甲基-D-天冬氨酸受体调节剂的构效关系。

The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.

作者信息

Strong Katie L, Epplin Matthew P, Bacsa John, Butch Christopher J, Burger Pieter B, Menaldino David S, Traynelis Stephen F, Liotta Dennis C

机构信息

Department of Chemistry, Emory University , 1515 Dickey Drive, Atlanta, Georgia 30322, United States.

Earth-Life Science Institute, Tokyo Institute of Technology , Meguro-ku, Tokyo Japan.

出版信息

J Med Chem. 2017 Jul 13;60(13):5556-5585. doi: 10.1021/acs.jmedchem.7b00239. Epub 2017 Jun 26.

Abstract

We have identified a series of positive allosteric NMDA receptor (NMDAR) modulators derived from a known class of GluN2C/D-selective tetrahydroisoquinoline analogues that includes CIQ. The prototypical compound of this series contains a single isopropoxy moiety in place of the two methoxy substituents present in CIQ. Modifications of this isopropoxy-containing scaffold led to the identification of analogues with enhanced activity at the GluN2B subunit. We identified molecules that potentiate the response of GluN2B/GluN2C/GluN2D, GluN2B/GluN2C, and GluN2C/GluN2D-containing NMDARs to maximally effective concentrations of agonist. Multiple compounds potentiate the response of NMDARs with submicromolar EC values. Analysis of enantiomeric pairs revealed that the S-(-) enantiomer is active at the GluN2B, GluN2C, and/or GluN2D subunits, whereas the R-(+) enantiomer is only active at GluN2C/D subunits. These results provide a starting point for the development of selective positive allosteric modulators for GluN2B-containing receptors.

摘要

我们已经鉴定出一系列源自已知的一类GluN2C/D选择性四氢异喹啉类似物(包括CIQ)的正变构NMDA受体(NMDAR)调节剂。该系列的原型化合物含有一个异丙氧基部分,取代了CIQ中存在的两个甲氧基取代基。对这种含异丙氧基支架的修饰导致鉴定出在GluN2B亚基上具有增强活性的类似物。我们鉴定出了能增强含GluN2B/GluN2C/GluN2D、GluN2B/GluN2C和GluN2C/GluN2D的NMDAR对最大有效浓度激动剂反应的分子。多种化合物能增强NMDAR的反应,其EC值为亚微摩尔。对映体对的分析表明,S-(-)对映体在GluN2B、GluN2C和/或GluN2D亚基上有活性,而R-(+)对映体仅在GluN2C/D亚基上有活性。这些结果为开发含GluN2B受体的选择性正变构调节剂提供了一个起点。

相似文献

引用本文的文献

6
Negative allosteric modulation of GluN1/GluN3 NMDA receptors.谷氨酸 N-甲基-D-天冬氨酸受体 GluN1/GluN3 的负变构调节。
Neuropharmacology. 2020 Oct 1;176:108117. doi: 10.1016/j.neuropharm.2020.108117. Epub 2020 May 7.

本文引用的文献

9
NMDA receptor modulators: an updated patent review (2013-2014).NMDA受体调节剂:最新专利综述(2013 - 2014年)
Expert Opin Ther Pat. 2014 Dec;24(12):1349-66. doi: 10.1517/13543776.2014.972938. Epub 2014 Oct 29.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验